JAZZ vs MDT: Side-by-Side Comparison
Compare Jazz Pharmaceuticals plc (JAZZ) and Medtronic Plc (MDT) side by side: market cap USD 15.28B vs USD 106.50B. Financials, growth and model signals on Bullrun.
| Metric | JAZZ | MDT |
|---|---|---|
| Company | Jazz Pharmaceuticals plc | Medtronic Plc |
| Country / Exchange | Ireland · NASDAQ | Ireland · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical Devices |
| Market cap | USD 15.28B | USD 106.50B |
| P/E ratio | — | 22.3 |
| Dividend yield | — | 1.72% |
| Valuation model | — | 14.6% undervalued |
| Revenue (FY2025) | USD 4.27B | USD 33.54B |
| Revenue growth YoY | +4.9% | +3.6% |
| Net income | USD -356.15M | USD 4.66B |
| Gross margin | — | 65.3% |
| Diluted EPS | -5.84 | 3.61 |